"celecoxib", "Celebrex"

ApprovedSmall molecule

EEsteve Pharmaceuticals, S.A.

"celecoxib", "Celebrex" is one of 157 small molecule programs targeting Glioma. It is currently in Approved.

Indications

Total Trials

Active Trials

156

Competitors

Pipeline

Status by Indication[3][1]

Indication

GliomaActive, not recruiting

FibromaActive, not recruiting

Total Knee ArthroplastyActive, not recruiting

Breast CancerActive, not recruiting

Diabetic Macular EdemaActive, not recruiting

Ankylosing SpondylitisActive, not recruiting

GliomaPhase 2

Active, not recruiting

FibromaPhase 2

Active, not recruiting

Total Knee ArthroplastyApproved

Active, not recruiting

Breast CancerPhase 2

Active, not recruiting

Diabetic Macular EdemaPhase 3

Active, not recruiting

Ankylosing SpondylitisPreclinical

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

"celecoxib", "Celebrex"

EEsteve Pharmaceuticals, S.A.

Approved

1 2

Tecentriq

Roche

Preclinical

36 3

DATROWAY

Daiichi Sankyo

Preclinical

4 4

Zolymbus

AbbVie

Preclinical

1 5

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

3 6

Effexor

WWyeth-Lederle Vaccines

Preclinical

2 7

Recentin

NNational Cancer Institute (NCI)

Preclinical

2 8

Acupan

YYonsei University

Preclinical

1 9

Avastin

Roche

Preclinical

4 10

Vfend

PPrism Pharmaceuticals

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2032

Phase 2Recruiting

Breast Cancer

NCT07104266

Clinical

Trials by Indication[1]

Ankylosing Spondylitis1 trial

A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

Completed·SSun Yat-sen University·N/A·NCT01709656·120 enrolled

Alzheimer's Disease1 trial

Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

Completed·SSeattle Institute for Biomedical and Clinical Research·Phase 3·NCT00007189·2,625 enrolled

Fibroma1 trial

Medical Treatment of "High-Risk" Neurofibromas

Completed·CCorewell Health West·Phase 2·NCT00846430·9 enrolled

Total Knee Arthroplasty1 trial

Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty

Completed·NNational Taiwan University Hospital·Phase 4·NCT00598234·120 enrolled

Clinical Trial1 trial

Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.

Completed·EEsteve Pharmaceuticals, S.A.·Phase 3·NCT03108482·637 enrolled

4 more indications

Glioma1 trial

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00504660·75 enrolled

Diabetic Macular Edema1 trial

Laser and Medical Treatment of Diabetic Macular Edema

Completed·NNational Eye Institute (NEI)·Phase 3·NCT00050479·100 enrolled

Breast Cancer1 trial

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Recruiting·UUniversité de Sherbrooke·Phase 2·NCT07104266·30 enrolled

Blood Pressure1 trial

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

Completed·UUniversity of Delaware·Phase 4·NCT00624559·12 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for "celecoxib", "Celebrex". U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — "celecoxib", "Celebrex" compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for "celecoxib", "Celebrex". EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Esteve Pharmaceuticals, S.A. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: EEsteve Pharmaceuticals, S.A.

"celecoxib", "Celebrex"

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2032

Trials by Indication[1]

Ankylosing Spondylitis1 trial

Alzheimer's Disease1 trial

Fibroma1 trial

Total Knee Arthroplasty1 trial

Clinical Trial1 trial

Glioma1 trial

Diabetic Macular Edema1 trial

Breast Cancer1 trial

Blood Pressure1 trial

References

Drug Info

Quick Facts

Related News